Skip to main content

Advertisement

Table 1 Baseline characteristics and medical treatment of patients

From: The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival

Variables Patients (n = 3)
Age (years) 60.7 ± 7.4
Male, n (%) 3 (100)
BMI (kg/m2) 27.3 ± 1.4
Smoking, n (%) 1 (33.3)
Hypertension, n (%) 3 (100)
Hyperlipidemia, n (%) 2 (66.7)
Leukocyte (109/L) 6.0 ± 0.6
Platelet (109/L) 197.3 ± 10.7
FBG (mmol/L) 5.5 ± 1.0
2h-PG (mmol/L) 10.5 ± 3.4
HbA1c (%) 7.0 ± 1.1
Blood urea nitrogen (mmol/L) 4.5 ± 0.3
Creatinine (μmol/L) 75.0 ± 6.7
Uric acid (mmol/L) 290.0 ± 37.6
hs-CRP (mg/L) 1.0 ± 0.5
Triglyceride (mmol/L) 1.2 ± 0.2
Total cholesterol (mmol/L) 4.7 ± 0.3
HDL-cholesterol (mmol/L) 1.1 ± 0.2
LDL-cholesterol (mmol/L) 3.2 ± 0.3
Lipoprotein (a) (g/L) 0.1 ± 0.03
Medications, n (%)
 Anti-platelet 3 (100)
 Beta-blocker 2 (66.7)
 ACE-I/ARB 2 (66.7)
 Statin 3 (100)
  1. BMI body mass index, FBG fasting blood glucose, 2h-PG 2h-postprandial glucose, hs-CRP high sensitivity C-reactive protein, HDL high-density lipoprotein, LDL low-density lipoprotein, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker